This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.63% per year. These returns cover a period from January 1, 1988 through December 2, 2019. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.
Visit performance for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fundamental Analysis: Archive
Brokers Suggest Investing in OneSpan (OSPN): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), OneSpan (OSPN) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
OSPN
Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Adma Biologics (ADMA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ADMA
Wall Street Analysts Think AGNC Investment (AGNC) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), AGNC Investment (AGNC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
AGNC
Is Newmont (NEM) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Newmont (NEM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
NEM
Wall Street Bulls Look Optimistic About Robinhood Markets (HOOD): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Robinhood Markets (HOOD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
HOOD
Alibaba (BABA) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Alibaba (BABA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BABA
Is Ares Capital (ARCC) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Ares Capital (ARCC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ARCC
Is Chipotle (CMG) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Chipotle (CMG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CMG
Is It Worth Investing in Synopsys (SNPS) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Synopsys (SNPS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SNPS
Is Spotify (SPOT) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Spotify (SPOT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SPOT
Compared to Estimates, Fastenal (FAST) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Fastenal (FAST) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
FAST
Unveiling Charles Schwab (SCHW) Q3 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Charles Schwab (SCHW), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.
SCHW
WaFd (WAFD) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Get a deeper insight into the potential performance of WaFd (WAFD) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
WAFD
Insights Into Commerce (CBSH) Q3: Wall Street Projections for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Commerce (CBSH) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
CBSH
What Analyst Projections for Key Metrics Reveal About Travelers (TRV) Q3 Earnings
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Travelers (TRV), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
TRV
Ahead of Interactive Brokers (IBKR) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Interactive Brokers (IBKR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.
IBKR
Countdown to Bank OZK (OZK) Q3 Earnings: Wall Street Forecasts for Key Metrics
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for Bank OZK (OZK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
OZK
Simmons First National (SFNC) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Evaluate the expected performance of Simmons First National (SFNC) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
SFNC
Curious about F.N.B. (FNB) Q3 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of F.N.B. (FNB) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
FNB
Curious about Snap-On (SNA) Q3 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Snap-On (SNA) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
SNA
The Bank of New York Mellon (BK) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for The Bank of New York Mellon (BK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
BK
Unlocking Q4 Potential of Commercial Metals (CMC): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Commercial Metals (CMC) for the quarter ended August 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
CMC
U.S. Bancorp (USB) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Evaluate the expected performance of U.S. Bancorp (USB) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
USB
Unlocking Q3 Potential of CSX (CSX): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for CSX (CSX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.
CSX
Stay Ahead of the Game With Marsh & McLennan (MMC) Q3 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Marsh & McLennan (MMC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.
MMC